Evidence map›Paper›PMID 41556159›Full record

ArticleInternational journal of surgery (London, England)2026

3,4-Dimethoxychalcone-induced caloric restriction inhibits PANoptosis to promote ischemic and diabetic skin flap survival: experimental studies.

Gaoxiang Yu, Jiayi Zhao, Xuwei Zhu, Ningning Yang, Junsheng Lou, Zhuliu Chen, Haojie Zhang, Tafadzwa Chaire, Weiyang Gao, Yuepiao Cai and 5 more

Abstract read
In one paragraph

Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gaoxiang YuDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Jiayi ZhaoDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Xuwei ZhuDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Ningning YangDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Junsheng LouDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Zhuliu ChenDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Haojie ZhangDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Tafadzwa ChaireMolecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Weiyang GaoDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Yuepiao CaiMolecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Xiangyang WangDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Jian DingDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Jian XiaoMolecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Kailiang ZhouDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Jianjun QiDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIschemic necrosis frequently affects the distal portion of skin flaps, particularly in diabetic patients. PANoptosis, a form of inflammatory programmed cell death, is implicated in vascular damage. This study examined whether 3,4-dimethoxychalcone (3,4-DC), a novel caloric restriction (CR) mimetic, could inhibit PANoptosis and promote the survival of ischemic and diabetic flaps.

methodsFlap viability was evaluated using laser Doppler blood flow imaging and histological analysis. Western blotting and immunofluorescence were used to assess PANoptosis and autophagy. Quantitative PCR was used to measure microRNA levels. Caspase-1 knockout and db/db mice were used to explore the effects of 3,4-DC on pyroptosis and diabetic complications.

results3,4-DC significantly improved ischemic flap survival and enhanced tissue perfusion. PANoptosis was inhibited, and autophagy was activated following 3,4-DC treatment, whereas these effects were abolished by the autophagy inhibitor chloroquine. Transcription factor EB (TFEB) inhibition reduced autophagy and reversed the protective effects of 3,4-DC. miR-107-3p was identified as a 3,4-DC-responsive microRNA that modulates TFEB nuclear translocation through the miR-107-3p/Wnt3a/mTOR pathway. Similar therapeutic effects were observed in diabetic flaps.

conclusion3,4-DC promotes the survival of ischemic and diabetic skin flaps by activating autophagy and inhibiting PANoptosis through the miR-107-3p/Wnt3a/mTOR/TFEB axis.

Indexed as

3,4-dimethoxychalconeautophagydiabetic flapsischemic flapsmiR-107-3pPANoptosis

Identifiers

PMID41556159
PMCPMC13105515

What Socratic holds

Textmetadata
LicenceCC BY-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.